Aspira Women’s Health (NASDAQ:AWH – Get Rating) will be issuing its quarterly earnings data after the market closes on Wednesday, March 22nd. Analysts expect the company to announce earnings of ($0.06) per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link.
Aspira Women’s Health Stock Down 4.5 %
Aspira Women’s Health stock opened at $0.38 on Wednesday. The stock has a market capitalization of $47.60 million, a PE ratio of -1.41 and a beta of 2.96. Aspira Women’s Health has a 12 month low of $0.29 and a 12 month high of $1.26. The business has a 50 day simple moving average of $0.47 and a 200-day simple moving average of $0.40. The company has a debt-to-equity ratio of 0.22, a current ratio of 3.15 and a quick ratio of 3.11.
Wall Street Analysts Forecast Growth
AWH has been the topic of a number of recent research reports. Cantor Fitzgerald lowered Aspira Women’s Health from an “overweight” rating to a “neutral” rating and lowered their price objective for the stock from $3.00 to $2.00 in a research note on Friday, January 20th. StockNews.com began coverage on Aspira Women’s Health in a research note on Monday, December 12th. They issued a “sell” rating on the stock.
Institutional Investors Weigh In On Aspira Women’s Health
About Aspira Women’s Health
Aspira Women’s Health, Inc engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
- Get a free copy of the StockNews.com research report on Aspira Women’s Health (AWH)
- Monoclonal Antibodies? Avid Bioservices surges 32% on Blowout Q3
- GitLab Crashes On Guidance; Analysts Defend
- Healthcare Stocks With at Least 30 Years of Dividend Increases
- Coinbase Pops As SVB Crumbles To Dust
- Airlines Update Guidance, Shares Head For Different Destinations
Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with MarketBeat.com's FREE daily email newsletter.